Scribd Logo
Upload

Welcome to Scribd!

  • NIDDK Director Griffin Rodgers To Speak at Duke 5/22/2012

    Uploaded by

    Duke Department of Medicine
    927 views1 page
    Griffin P. Rodgers, M.d., is a physicianscientist. He is internationally recognized for his contributions to the development of the first effective - and now FDA approved - therapy for sickle cell anemia. As Director of the NIDDK, he oversees an annual budget of $2 billion.

    Original Description:

    Original Title

    NIDDK Director Griffin Rodgers to speak at Duke 5/22/2012

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Griffin P. Rodgers, M.d., is a physicianscientist. He is internationally recognized for his contributions to the development of the first effective - and now FDA approved - therapy for sickle cell anemia. As Director of the NIDDK, he oversees an annual budget of $2 billion.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    927 views1 page

    NIDDK Director Griffin Rodgers To Speak at Duke 5/22/2012

    Uploaded by

    Duke Department of Medicine
    Griffin P. Rodgers, M.d., is a physicianscientist. He is internationally recognized for his contributions to the development of the first effective - and now FDA approved - therapy for sickle cell anemia. As Director of the NIDDK, he oversees an annual budget of $2 billion.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    The Duke University School of Medicine invites you to attend a lecture by Griffin P. Rodgers, M.D.

    , Director, The National Institute of Diabetes, Digestive Diseases and Kidney Diseases (NIDDK), and Chief, Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute

    Tuesday May 22

    5:006:00 p.m.
    Searle Center
    Students and Faculty Welcome Dr. Rodgers is a physicianscientist who is internationally recognized for his contributions to the development of the first effective and now FDA approved therapy for sickle cell anemia and other genetic diseases of hemoglobin. He also performed basic research focusing on understanding the molecular basis of how certain drugs induce gamma-globin expression. As Director of the NIDDK, he oversees an annual budget of $2 billion and a staff of more than 600 scientists, physicianscientists and administrators.

    In Vitro Model for Studying Lineage-Specific Differentiation and Plasticity of Hematopoietic Stem Cells

    You might also like